A Study of Sigvotatug Vedotin in Advanced Solid Tumors

NCT04389632 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

1006

Enrollment

INDUSTRY

Sponsor class

Conditions

Carcinoma, Non-Small Cell Lung
Squamous Cell Carcinoma of Head and Neck
HER2 Negative Breast Neoplasms
Esophageal Squamous Cell Carcinoma
Esophageal Adenocarcinoma
Gastroesophageal Junction Adenocarcinoma
Ovarian Neoplasms
Cutaneous Squamous Cell Cancer
Exocrine Pancreatic Adenocarcinoma
Urinary Bladder Neoplasms
Uterine Cervical Neoplasms
Stomach Neoplasms

Interventions

DRUG: sigvotatug vedotin
DRUG: pembrolizumab
DRUG: cisplatin
DRUG: carboplatin

Sponsor

Seagen, a wholly owned subsidiary of Pfizer